Steven Cohen Ptc Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 26,700 shares of PTCT stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,700
Previous 26,700
-0.0%
Holding current value
$1.18 Million
Previous $816,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding PTCT
# of Institutions
223Shares Held
79.3MCall Options Held
122KPut Options Held
207K-
Vanguard Group Inc Valley Forge, PA8.97MShares$397 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$363 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$344 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$327 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$308 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.17B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...